Article
Point mutations in the ygiV promoter region lead to cystobactamid resistance and reduced virulence in E. coli
2024-01-05
Abstract excerpt
<title>Abstract</title> <p>Antimicrobial resistance is one of the major health threats of the modern world. Thus, new structural classes of antimicrobial compounds are needed in order to overcome existing resistance. Cystobactamids as such a new compound class inhibit the well-established target bacterial type II topoisomerases while exhibiting superior antibacterial and resistance-breaking properties. Understand...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 140a7654-12bc-5ebf-975b-47f669d1ecff
- DOI
- 10.21203/rs.3.rs-3751821/v1
